Impressive results with transthyretin-stabilizer that reduces mortality and hospitalization in patients with transthyretin-related cardiomyopathy
3' education - Aug. 27, 2018 - Prof. Claudio Rapezzi, Bologna, ItalyEducational information
This 3-minute education provides a summary of just presented scientific data, recorded during the ESC 2018 congress. The objective is to provide a brief commentary and potential implications of these findings.
Faculty
Claudio Rapezzi is Associate Professor in Bologna, Italy
Disclosures
The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this 3-minute education.